Quintiles KoNECT’s with South Korea’s trial sector

By Gareth Macdonald

- Last updated on GMT

Related tags: South korea, Clinical trial, Contract research organization

Quintiles will help South Korea develop its clinical research infrastructure under a new collaboration with the Korea National Enterprise for Clinical trials (KoNECT).

Under a memorandum of understanding announced late yesterday the US contract research organisation (CRO) will collaborate on a number of ‘educational events’ for trial investigators, government officials and biopharmaceutical firms.

MiSook Hyun, who heads Quintiles operations in South Korea, said: “With KoNECT we can further enhance the already high clinical research standards that exist here and expand its clinical research capacity​.”

This was echoed by KoNECT President Sang-Goo Shin who said: “Together we hope to improve clinical research expertise and build a support infrastructure in Korea that’s second to none​.”

KoNECT was established by the South Korean government in 2007 as a way of co-ordinating together academic, governmental and industrial efforts to develop the countries clinical trial infrastructure.

Quintiles​, which has operated in South Korea for more than a decade, is not the only CRO to have shown a renewed interest in the country as a trial destination since KoNECT was launched.

For example, Parexel​, Novotech​, Siro Clinpharm ​and PRA​ have all begun conducting clinical research in South Korea in recent years.

Additionally, in April​ this year, Ireland-based CRO Icon said it had seen an uptick in demand from Japanese biopharma clients for clinical trials conducted in the Asia Pacific with South Korea being one of the areas of strongest growth.

This expansion is also reflected by data from the Clinicaltrials.gov​ website, which showed that Clinical trials initiated annually in South Korea increased by 150 per cent between 2006 and 2009.

Related news

Show more

Related products

show more

What are the building blocks of DCTs?

What are the building blocks of DCTs?

Medable | 26-Apr-2021 | Technical / White Paper

How to create a seamless experience across eConsent, eCOA and more.

Over the past year, tremendous progress was made toward digitizing and...

How a clinical metadata repository helps with data

How a clinical metadata repository helps with data

Formedix | 22-Mar-2021 | Technical / White Paper

This article covers the various ways a clinical metadata repository helps with data quality, and in turn, with data quality in the clinical trials process....

Introduction to eLAS®

Introduction to eLAS®

Clinical Ink | 08-Mar-2021 | Product Brochure

Clinical Ink has developed a unique offering — the electronic Lupus Assessment Suite (eLAS®) to address fundamental challenges impacting systemic lupus...

Related suppliers

Follow us


View more